Cardinal Health, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Cardinal Health, Inc. (CAH) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $1.91 billion for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-11.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-08-11
- Cardinal Health, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2026 was $1.91B, a 14.92% decline from fiscal 2025.
- Cardinal Health, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $2.25B, a 3.06% decline from fiscal 2024.
- Cardinal Health, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $2.32B, a 2.73% decline from fiscal 2023.
- Cardinal Health, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $2.38B, a 3.52% decline from fiscal 2022.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month as first filed |
|---|---|---|
| 2026-06-30 | $1.91B 10-K · filed 2026-08-11 | |
| 2025-06-30 | $2.25B 10-K · filed 2026-08-11 | |
| 2024-06-30 | $2.32B 10-K · filed 2026-08-11 | |
| 2023-06-30 | $2.38B 10-K · filed 2025-08-12 | $2.41B 10-K · filed 2023-08-15 |
| 2022-06-30 | $2.47B 10-K · filed 2024-08-14 | $2.51B 10-K · filed 2022-08-11 |
| 2021-06-30 | $2.70B 10-K · filed 2023-08-15 | |
| 2020-06-30 | $2.41B 10-K · filed 2022-08-11 | |
| 2019-06-30 | $2.35B 10-K · filed 2021-08-16 | |
| 2018-06-30 | $2.51B 10-K · filed 2020-08-13 | |
| 2017-06-30 | $2.35B 10-K · filed 2019-08-20 | |
| 2016-06-30 | $2.29B 10-K · filed 2018-08-22 | |
| 2015-06-30 | $2.05B 10-K · filed 2017-08-10 | |
| 2014-06-30 | $1.79B 10-K · filed 2016-08-12 | |
| 2013-06-30 | $332.00M 10-K · filed 2015-08-13 | $41.00M 10-K · filed 2013-08-20 |
| 2012-06-30 | $22.00M 10-K · filed 2014-08-13 | |
| 2011-06-30 | $27.00M 10-K · filed 2013-08-20 | $27.20M 10-K · filed 2011-08-26 |
| 2010-06-30 | $27.00M 10-K · filed 2012-08-22 | $26.80M 10-K/A · filed 2010-09-02 |
| 2009-06-30 | $51.40M 8-K/A · filed 2011-11-04 | |
| 2008-06-30 | $19.90M 10-K/A · filed 2010-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |